UOC
UBS O'Connor Portfolio holdings
AUM
$3.76B
Turnover
54.76%
1-Year Est. Return
62.41%
This Fund
S&P 500
This Quarter
Est. Return
+13.06%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$4.23B
AUM Growth
+$208M
(+5.2%)
Cap. Flow
+$22.5M
Cap. Flow
% of AUM
0.53%
Top 10 Holdings %
Top 10 Hldgs %
66.8%
Holding
503
New
83
Increased
81
Reduced
97
Closed
181
Avg Time Held Equity + Options
1.1
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
1.1
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intra-Cellular Therapies Inc.
ITCI
|
+$383M |
| 2 |
Discover Financial Services
DFS
|
+$224M |
| 3 |
Beacon Roofing Supply, Inc.
BECN
|
+$183M |
| 4 |
Walgreens Boots Alliance
WBA
|
+$110M |
| 5 |
Nordstrom
JWN
|
+$95.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HashiCorp, Inc. Class A Common Stock
HCP
|
+$235M |
| 2 |
Smartsheet Inc.
SMAR
|
+$216M |
| 3 |
Endeavor Group Holdings, Inc.
EDR
|
+$144M |
| 4 |
Summit Materials, Inc. Class A Common Stock
SUM
|
+$103M |
| 5 |
Altair Engineering Inc
ALTR
|
+$97.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 17.21% |
| 2 | Healthcare | 16.93% |
| 3 | Financials | 12.93% |
| 4 | Industrials | 12.5% |
| 5 | Technology | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
401
Cypherpunk Technologies Inc
CYPH
$282M
| – | – |
-105,108
| Closed | -$302K | – |
|
402
McDonald's
MCD
$169B
| – | – |
-7,500
| Closed | -$2.17M | – |
|
403
Magnite
MGNI
$3.42B
| – | – |
-50,000
| Closed | -$797K | – |
|
404
MoonLake Immunotherapeutics
MLTX
$863M
| – | – |
-20,740
| Closed | -$1.12M | – |
|
405
3M
MMM
$84.8B
| – | – |
-56,300
| Closed | -$7.27M | – |
|
406
Marvell Technology
MRVL
$220B
| – | – |
-5,000
| Closed | -$552K | – |
|
407
Strategy Inc
MSTR
$60.7B
| – | – |
-2,937
| Closed | -$851K | – |
|
408
Neurocrine Biosciences
NBIX
$13.8B
| – | – |
-23,111
| Closed | -$3.15M | – |
|
|
409
PUT
Neurocrine Biosciences
NBIX
$13.8B
| – | – |
-15,000
| Closed | -$18K | – |
|
410
Minerva Neurosciences
NERV
$112M
| – | – |
-107,256
| Closed | -$238K | – |
|
411
PUT
Nike
NKE
$52.4B
| – | – |
-68,000
| Closed | -$84K | – |
|
412
ServiceNow
NOW
$145B
| – | – |
-2,190
| Closed | -$464K | – |
|
413
NetEase
NTES
$79.2B
| – | – |
-36,000
| Closed | -$3.21M | – |
|
414
PUT
Novo Nordisk
NVO
$168B
| – | – |
-10,000
| Closed | -$15.2K | – |
|
415
ON Semiconductor
ON
$28.6B
| – | – |
-27,500
| Closed | -$1.73M | – |
|
416
Oracle
ORCL
$396B
| – | – |
-20,729
| Closed | -$3.45M | – |
|
417
Ovid Therapeutics
OVID
$428M
| – | – |
-943,416
| Closed | -$881K | – |
|
418
Occidental Petroleum Corp Warrants
OXY.WS
$37.1B
| – | – |
-300,000
| Closed | -$8.25M | – |
|
419
Palo Alto Networks
PANW
$307B
| – | – |
-1,412
| Closed | -$257K | – |
|
420
PACCAR
PCAR
$57.1B
| – | – |
-25,000
| Closed | -$2.6M | – |
|
421
PagerDuty
PD
$1.31B
| – | – |
-22,500
| Closed | -$411K | – |
|
422
Pliant Therapeutics
PLRX
$54.7M
| – | – |
-103,563
| Closed | -$1.36M | – |
|
423
CALL
Praxis Precision Medicines
PRAX
$6.67B
| – | – |
-10,000
| Closed | -$41.8K | – |
|
424
ProQR Therapeutics
PRQR
$207M
| – | – |
-227,020
| Closed | -$602K | – |
|
425
Pyxis Oncology
PYXS
$149M
| – | – |
-146,400
| Closed | -$228K | – |
|
Similar funds
FNBT
ACI
RC
A
CGL
CB
JCM
MPM
UBS O'Connor's Q1 2025 Portfolio in Review
As of Q1 2025, UBS O'Connor held 503 positions worth $4.23B, up 5.2% from $4.02B the previous quarter. Its ten largest holdings account for 67% of the portfolio.
UBS O'Connor's Q1 2025 filing shows 83 new, 81 increased, 97 reduced and 181 closed positions. Its largest new stake was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M. The largest sale was HashiCorp, Inc. Class A Common Stock, an estimated $235M.
By sector, the portfolio is most concentrated in Energy at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- UBS O'Connor's largest Q1 2025 buy was Beacon Roofing Supply, Inc.: 1,575,016 shares worth $195M.
- UBS O'Connor added most to Intra-Cellular Therapies Inc. in Q1 2025, an estimated $383M increase.
- UBS O'Connor's biggest Q1 2025 reduction was Juniper Networks, cutting an estimated $71.4M.
- UBS O'Connor fully exited HashiCorp, Inc. Class A Common Stock in Q1 2025, selling an estimated $235M.
- UBS O'Connor's ten largest holdings make up 67% of its $4.23B portfolio in Q1 2025.
- UBS O'Connor opened 83 new positions and closed 181 in Q1 2025.
- UBS O'Connor's portfolio value rose 5.2% quarter-over-quarter to $4.23B.
Based on UBS O'Connor's 13F filing for Q1 2025, filed 15 May 2025.